Used in peptide synthesis as a chiral building block, particularly in the preparation of complex bioactive molecules. Its morpholine ring enhances solubility and can influence the conformation of the resulting peptide, improving target binding or metabolic stability. Commonly employed in the development of pharmaceuticals where stereochemistry is critical, such as protease inhibitors or enzyme modulators. The Fmoc group allows for mild, base-labile protection in solid-phase synthesis, making it compatible with a wide range of side-chain protecting groups. Also utilized in research settings for labeling, conjugation, and the construction of peptidomimetics.